4/9
08:44 am
vinc
Vincerx Pharma, Inc. (NASDAQ: VINC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
High
Report
Vincerx Pharma, Inc. (NASDAQ: VINC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
4/8
04:38 pm
vinc
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
High
Report
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
4/8
04:30 pm
vinc
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
High
Report
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
4/1
12:17 pm
vinc
Vincerx Pharma, Inc. (NASDAQ: VINC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
High
Report
Vincerx Pharma, Inc. (NASDAQ: VINC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
4/1
08:19 am
vinc
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
High
Report
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
4/1
08:00 am
vinc
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
High
Report
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
3/29
03:39 pm
vinc
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update [Yahoo! Finance]
High
Report
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update [Yahoo! Finance]
3/29
03:20 pm
vinc
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
High
Report
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
3/6
01:06 pm
vinc
OCEA, RVSN and HOVR among mid-day movers [Seeking Alpha]
Medium
Report
OCEA, RVSN and HOVR among mid-day movers [Seeking Alpha]
3/5
04:43 pm
vinc
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
High
Report
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]
3/5
04:31 pm
vinc
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
High
Report
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
3/5
06:25 am
vinc
Vincerx Pharma, Inc.'s (NASDAQ:VINC) large institutional owners must be happy as stock continues to impress, up 28% over the past week [Yahoo! Finance]
Medium
Report
Vincerx Pharma, Inc.'s (NASDAQ:VINC) large institutional owners must be happy as stock continues to impress, up 28% over the past week [Yahoo! Finance]